Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
CorMedix Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
CRMD
Nasdaq
2834
https://cormedix.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for CorMedix Inc
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
- Apr 19th, 2024 12:30 pm
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
- Apr 15th, 2024 12:30 pm
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
- Apr 11th, 2024 12:30 pm
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
- Apr 8th, 2024 12:30 pm
Breakeven On The Horizon For CorMedix Inc. (NASDAQ:CRMD)
- Apr 2nd, 2024 3:10 pm
CorMedix Inc. to Present at the Needham Annual Healthcare Conference
- Mar 27th, 2024 12:30 pm
Cormedix Inc (CRMD) Reports Increased Operating Expenses Amid Pre-Launch Activities for DefenCath
- Mar 12th, 2024 12:51 pm
CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Mar 12th, 2024 11:30 am
CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024
- Mar 6th, 2024 1:30 pm
CorMedix Inc. Announces Commercial and Reimbursement Updates
- Jan 30th, 2024 1:30 pm
CorMedix Inc. Announces Commercial and Operational Updates
- Jan 8th, 2024 1:30 pm
CorMedix Inc. Announces Appointment of Chief Legal Officer
- Dec 15th, 2023 1:30 pm
CorMedix Inc. Announces Partnership With The Leapfrog Group
- Dec 4th, 2023 1:30 pm
CorMedix Inc. Announces FDA Approval of DefenCath® to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients
- Nov 15th, 2023 5:57 pm
Cormedix Inc (CRMD) Reports Increased Operating Expenses Amid Pre-Launch Activities in Q3 2023
- Nov 14th, 2023 11:03 pm
CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update
- Nov 14th, 2023 9:05 pm
CorMedix Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on November 14, 2023
- Nov 2nd, 2023 12:30 pm
CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference
- Oct 11th, 2023 12:30 pm
CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
- Sep 26th, 2023 12:30 pm
CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology
- Sep 8th, 2023 12:30 pm
Scroll